Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.

Over the past decade, various reports have suggested that the anti-muscarinic drug clemastine can stimulate remyelination by oligodendrocytes. Consequently, the repurposing of clemastine as a ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Stay informed on the latest scams with a free biweekly newsletter ...

The US Food and Drug Administration (FDA) has approved dupilumab for the treatment of chronic spontaneous urticaria (CSU) in patients aged 12 years and older who “remain symptomatic despite H1 ...

Many drugs commonly prescribed to the elderly have anticholinergic properties. Due to the current clinical use of drugs with mild-to-modest anticholinergic activity, the clinical manifestations of ...

drug reactions including drug allergy. Head of Drug information at Clinical pharmacology, Karolinska University Laboratory, Karolinska University Hospital. Other important factors are ...